The table below shows BIO-TECHNE Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2025
Q3 2024
Q3 2023
Q3 2022
Q3 2021
Q3 2020
Operating cash flow
$27.59M
$63.89M
$59.38M
$56.08M
$48.43M
$66.01M
Capital expenditure
$5.36M
$9.17M
$13.59M
$9.56M
$6.07M
$10.94M
Investing cash flow
$605.00K
-$21.68M
-$154.11M
-$19.69M
-$7.12M
-$8.14M
Dividends paid
$12.44M
$12.69M
$12.65M
$12.54M
TECH operating cash flow (10-K history)
BIO-TECHNE Corp reported operating cash flow of $287.56M for fiscal year 2025. That is down 3.8% from $298.98M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $144.16M (FY 2016) to $287.56M. Figures come from the company's audited annual reports as filed with the SEC.
